Medtronic’s DES Moment Of Truth: ACC Is Venue For Endeavor Results
This article was originally published in The Gray Sheet
Executive Summary
Data from Medtronic's ENDEAVOR-II clinical trial, to be presented to the American College of Cardiology March 6, will reveal whether the company is on track to launch its drug-eluting stent in the U.S. by early 2006